Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anup Shah

Sports Medicine Phoenix, AZ Medical Doctor

NPI 1336323799 CMS profile 60099

755 E McDowell Rd, Phoenix, AZ 85006

Open in the dashboard

General payments

$1,331,872

610 records reported · program years 2019–2025

Research payments

$10,275

Paid to them · 7 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$140,721 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Anup Shah of Phoenix, AZ is reported in the CMS Open Payments database as having received $1,331,872 across 610 general payments and $10,275 in research payments paid to them. Separately, studies naming them as principal investigator received $140,721 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $287,963 159
2025 Research $4,400 3
2024 General $234,273 120
2024 Research $2,475 2
2023 General $173,243 94
2023 Research $3,400 2
2022 General $148,240 98
2021 General $143,810 45
2020 General $165,482 28
2019 General $178,863 66

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anup Shah
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Anup Shah were reported at $287,963. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Anup Shah Sports Medicine median Middle half National median
2019 $178,863 $1,176 $199–$4,249 $163
2020 $165,482 $708 $96–$2,890 $114
2021 $143,810 $1,213 $152–$3,994 $132
2022 $148,240 $1,230 $159–$3,998 $149
2023 $173,243 $584 $146–$2,836 $160
2024 $234,273 $628 $163–$3,168 $164
2025 $287,963 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medacta USA, Inc. $960,327 135 payments
  2. Arthrex, Inc. $356,086 378 payments
  3. ImpactOrtho, Inc. $10,681 46 payments
  4. DePuy Synthes Products, Inc. $1,170 1 payment
  5. Stryker Corporation $1,018 9 payments
  6. Zimmer Biomet Holdings, Inc. $629 8 payments
  7. Exactech, Inc. $396 3 payments
  8. Smith+Nephew, Inc. $318 3 payments
  9. Pacira Pharmaceuticals Incorporated $234 1 payment
  10. DePuy Synthes Sales Inc. $130 4 payments
  11. Other $885 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $682,677 32 payments
  2. Consulting Fee $418,314 66 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $134,400 13 payments
  4. Travel and Lodging $56,902 162 payments
  5. Food and Beverage $17,980 329 payments
  6. Honoraria $13,200 1 payment
  7. Education $8,400 7 payments
Products named General payments · program years 2019–2025
  1. PRIMARY SHOULDER Shoulder $702,462 77 payments
  2. Shoulder System $156,223 7 payments
  3. Primary Shoulder Orthopedics/Orthopedic Surgery $75,456 4 payments
  4. NextAR Shoulder $16,635 1 payment
  5. GMK SPHERE $2,197 23 payments
  6. AMISTEM $2,118 23 payments
  7. ARTHROPLASTY IMPLANTS SHOULDER ARTHROPLASTY & FRACTURE REVERS $1,063 1 payment
  8. ARTHROPLASTY IMPLANTS SHOULDER ARTHROPLASTY & FRACTURE UNIVERS $1,063 1 payment
  9. REVERSE SHOULDER $769 19 payments
  10. AEQUALIS PERFORM $454 4 payments
  11. Other $4,856 65 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Arthrex, Inc. $10,275 7 payments

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$80,585

Of which drugs: $3,024

Medicare patients

189

Average age 74

Services billed

769

100 women, 89 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 70%
Ischemic heart disease 29%
Chronic kidney disease 28%
Depression 23%
Diabetes 22%
Cancer 16%
Osteoporosis 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 26 224 $173

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

617 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record